EPO Patents = 1

Trademarks = 1

Forward Citations = 46

Loading Chart...

2 inventors (with patents filed for the assignee):

Moshe Sarfaty (5 out of 25 patents)

Amir Lev (5 out of 5 patents)

5 patents: Sort by Forward Citations

1. 9566030 - Optical system for detection and characterization of abnormal tissue and cells (2017-02-14),

2. 9554743 - Methods for optical identification and characterization of abnormal tissue and cells (2017-01-31),

3. 8865076 - Methods for detection and characterization of abnormal tissue and cells using an electrical system (2014-10-21),

4. 8437845 - Electrical methods for detection and characterization of abnormal tissue and cells (2013-05-07),

5. 8417328 - Electrical systems for detection and characterization of abnormal tissue and cells (2013-04-09),

Company Overview

Ls Biopath, Inc. is a biotechnology company focused on developing innovative solutions for healthcare industry. With cutting-edge technology and a team of experts, we aim to revolutionize the field of biopathology and improve patient outcomes. Our products range from diagnostic tools to personalized treatments, all designed to meet the evolving needs of the medical community.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#30 in Saratoga, CA

#12,070 in California

#51,620 in US

Saratoga, CA, United States of America

Ls Biopath, Inc.

Forward Citations = 46

2 inventors:

Moshe Sarfaty (5 out of 25 patents)

Amir Lev (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ls Biopath, Inc.. Retrieved from https://idiyas.com/company/ls-biopath

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]